The clinical-stage biopharmaceutical company said the Phase 3 study didn't demonstrate a statistically significant improvement on the primary endpoint of change from baseline in a scale that measures ...
Almost Three Quarters of Adolescents Experience Depression or Anxiety Dec ... treating depression in patients for whom standard treatments have been ...